Lidocaine Hcl Injection, Solution
Product Images NDC 51662-1596

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lidocaine Hcl (NDC 51662-1596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pouch (15662 1596 2 Pouch Labeling Sept 2022)

Pouch (15662 1596 2 Pouch Labeling Sept 2022)
Label for LIDOCAINE HCl Injection, USP 200 mg/5 mL (40 mg/mL) in a 5 mL ampule. The label includes the NDC 51662-1596-2, lot number, expiration date, barcode, and storage instructions. It states use for topical and retrobulbar injection, preservative-free, manufactured by HF Acquisition Co., LLC.*
FDA Label Image

Case (15662 1596 3 Case Labeling Sept 2022)

Case (15662 1596 3 Case Labeling Sept 2022)
Label for Lidocaine HCl Injection, USP 40 mg/mL (4%) in 5 mL ampules, packaged as a case of 25. It indicates topical and retrobulbar injection routes, preservative-free formulation, and includes manufacturer and lot information. The label shows the NDC 51662-1596-3 and details storage instructions and usage restrictions.*
FDA Label Image

Rfid (51662 1596 3 Serialized Rfid Labeling Sept 2022)

Rfid (51662 1596 3 Serialized Rfid Labeling Sept 2022)
A white box label for LIDOCAINE HCl injection, solution, including a barcode with numeric codes, NDC 00351662159637, and distributor information showing HF Acquisition Co., LLC based in Mukilteo, WA. It references the manufacturer’s package insert and indicates RX only status.*
FDA Label Image

Amp (Amp Label Sept 2022)

Amp (Amp Label Sept 2022)
Label for Lidocaine HCl Injection, USP 4% (40 mg/mL), 5 mL single-dose, preservative-free solution. The label indicates use for topical and retrobulbar injection only. Distributed by Hospira, Inc., Lake Forest, IL, USA. Includes NDC 0409-4283-11 and placeholders for lot and expiration date.*
FDA Label Image

Precautions (Precautions)

Precautions (Precautions)
A data table listing drug classes in the left column and examples in the right column. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with examples such as lidocaine listed under Local anesthetics.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of lidocaine hydrochloride monohydrate illustrating the aromatic ring with two methyl groups, an amide linkage, and associated hydrochloride and water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.